Lastly, Chiu and colleagues reported quantification of plasma Tau by SQUID-IMR (as described earlier for detection of plasma Aβ) and showed an increase in plasma tau in MCI and AD, along with an association of plasma tau with clinical measures of cognition and regional brain volume (57). This evidence concerns the gene MAPT and Alzheimer disease.